healthcare

Latest news and analysis on healthcare

Equities

9 early-stage stocks catching fire - and the market’s attention

From nuclear microreactors to AI-powered medicine, these ASX and international early-stage companies are drawing serious investor interest.
Vishal Teckchandani
Livewire Markets
Equities

2 stocks to drive future performance following a 35% return in six months

With our fund up 35%+ in six months, we're looking at undervalued healthcare opportunities in the market to drive future returns.
CSL
Romano Sala Tenna
Katana Asset Management
Reporting Season

Are CSL's best days behind it?

After announcing soft guidance, a spin off of its vaccines unit, and plans to cut 3000 jobs, investors are pondering CSL's future.
CSL
Chris Conway
Livewire Markets
Equities

Founder-led focus meets demographic tailwinds: A decade-long runway

Penumbra's aspiration-based mechanical thrombectomy devices are building one of the most defensible competitive moats in medical technology
Jacob Celermajer
Cordis Asset Management
Investment Theme

Why a little-known policy change has big implications for medtech

In a sector where utilisation and reimbursement are tightly linked, reduction in admin drag supports more stable, visible revenue streams.
COH
Jacob Celermajer
Cordis Asset Management
Equities

Resilience and growth in the heart of healthcare: why Pella invests in medical devices

In a world defined by macroeconomic uncertainty and shifting geopolitical realities, Pella continues to find opportunities.
Steven Glass
Pella Funds Management
Equities

A gameplan for healthcare investing amid policy uncertainty

Despite growing policy uncertainty, plenty of healthcare companies have managed to put up big returns, thanks to these qualities.
Andy Acker
Janus Henderson
The Pitch

Where are the hottest opportunities to make money from AI?

The next beneficiaries of the AI boom may not just be leaders like Nvidia. Global X’s Billy Leung discusses the next wave of winners.
Vishal Teckchandani
Livewire Markets
Equities

Nutex Health - Emergency room level of potential upside

Despite a five-fold share price increase, this US micro cap is still a bargain.
Steve Johnson
Forager
Equities

The 4 biotech firms the experts are most excited about

Platinum Asset Management’s Dr Bianca Ogden and KP Rx’s Hashan de Silva share their latest investments.
Sara Allen
Livewire Markets
Equities

The under-the-radar healthcare stock leading the world in cataract treatment

Antipodes Healthcare Portfolio Manager, Nick Cameron, outlines the investment case for pharmaceutical and medical device company, Alcon AG.
Antipodes Partners
Antipodes
Equities

Telix eyes strong growth in 2025, but RFK Jr. poses a wildcard: Shane Fitzgerald

Telix smashes revenue forecasts with $1.2B+ guidance, but RFK Jr. & U.S. regulatory chaos pose risks. Shane Fitzgerald remains bullish.
Vishal Teckchandani
Livewire Markets
Equities

"I’ll be buying" – Why Jun Bei Liu sees more upside in Pro Medicus

Despite sky-high valuations, Jun Bei Liu is bullish on Pro Medicus. She first bought at $25 - now it’s 10x’d. How much higher can it climb?
PME
Vishal Teckchandani
Livewire Markets
Equities

CSL falls short, despite $8.48 billion revenue

Plasma is still a winner for the healthcare giant, but vaccinations face hurdles.
CSL
Sara Allen
Livewire Markets
Equities

The ASX medtech innovator positioned for growth

This commercial med-tech is valued at just ~A$40m despite having innovative tech, market adoption and a partnership with a global giant.
4DX
CVB
EBR
+2
Hashan De Silva
KP Rx
Reporting Season

ResMed's latest earnings are "super impressive", says this fund manager

Could this Australian-American healthcare stalwart hit $60/share?
RMD
Hans Lee
Livewire Markets
Property

A once-in-a-cycle healthcare real estate opportunity is available right now

Real Asset Management's Matthew Strotton is bullish on this often overlooked area of healthcare real estate investing.
Sara Allen
Livewire Markets
Funds

Ignore the noise: These Australian property investments are alive with opportunity

In this wire, we explain why one of our flagship funds shifted to a full-time healthcare focus.
Matthew Strotton
Real Asset Management
Equities

How this healthcare stock exemplifies steady compounding

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a beneficiary.
Ella-Kara Brown
Amova AM
Alternatives in Focus

4 resilient themes with strong tailwinds

Wilson Asset Management’s Dania Zinurova explains the big themes she chases for WAM Alternative Assets through her investments.
Sara Allen
Livewire Markets
1-20 of 204